Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18908215 | Termite Trailing and Recruitment Product and Process | October 2024 | April 2025 | Allow | 6 | 1 | 0 | Yes | No |
| 18253226 | PROCESS FOR MAKING SANITIZING LOTION THAT CAN BE USED AS A MOISTURIZER, MAKEUP REMOVER AND OTHER USES | May 2023 | January 2026 | Allow | 32 | 2 | 0 | Yes | No |
| 18186996 | DEVELOPER COMPOSITION COMPRISING DIRECT DYE | March 2023 | January 2026 | Abandon | 34 | 1 | 0 | No | No |
| 18108395 | COMPOSITIONS, APPARATUSES AND METHODS FOR MAKING AND USING BIOSCAFFOLDS | February 2023 | January 2026 | Allow | 35 | 1 | 1 | Yes | No |
| 18006717 | NOVEL ORGANIC FUNGICIDE FOR USE AGAINST FUSARIUM WILT | January 2023 | November 2025 | Abandon | 34 | 0 | 1 | No | No |
| 18085752 | COSMETIC COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE FOR SOOTHING EFFECT ON THE SKIN | December 2022 | June 2025 | Allow | 30 | 1 | 0 | Yes | No |
| 18011867 | METHOD FOR MANUFACTURING A MULTI-LAYERED FILM STRUCTURE AND METHOD FOR MANUFACTURING MULTI-LAYERED MICROSTRUCURES | December 2022 | November 2025 | Abandon | 35 | 0 | 1 | No | No |
| 18067670 | FRUIT TREE POLLINATION METHOD FOR PREVENTING AND CONTROLLING ERWINIA AMYLOVORA-CAUSED DISEASE | December 2022 | December 2025 | Abandon | 36 | 1 | 0 | No | No |
| 18000219 | MICROBIOCIDAL DERIVATIVES | November 2022 | January 2026 | Allow | 38 | 2 | 0 | Yes | No |
| 17913469 | Taste Masked And Rapidly Disintegrating Ultra Thin Iron Orodispersible Film And A Process Thereof | September 2022 | October 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17911500 | PERSONAL CARE COMPOSITION, METHOD FOR USING SUCH COMPOSITIONS AND ITS IMPROVEMENT OF DEPOSITION EFFECT | September 2022 | February 2026 | Abandon | 41 | 2 | 0 | No | No |
| 17862377 | MOLDABLE MEDICAL MEMBRANE | July 2022 | December 2025 | Abandon | 41 | 4 | 0 | No | No |
| 17714313 | HETEROCYCLIC RED AZO COLORANTS FOR SEED TREATMENT APPLICATIONS | April 2022 | April 2025 | Allow | 36 | 1 | 0 | Yes | No |
| 17762137 | LACTIC ACID VAGINAL FILM AND IT'S PROCESS | March 2022 | October 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17697066 | Effervescent Tablet and Composition for Masking Toilet Odors and Method of Use Thereof | March 2022 | May 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17507141 | METHODS AND APPARATUS FOR FORMING ANTIMICROBIAL FILM | October 2021 | March 2026 | Abandon | 52 | 5 | 1 | No | No |
| 17245480 | COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS | April 2021 | December 2025 | Abandon | 55 | 5 | 1 | No | No |
| 16999935 | PATHOGEN INHIBITOR | August 2020 | January 2026 | Abandon | 60 | 5 | 1 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner ZHANG SPIERING, DONGXIU works in Art Unit 1616 and has examined 3 patent applications in our dataset. With an allowance rate of 0.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 55 months.
Examiner ZHANG SPIERING, DONGXIU's allowance rate of 0.0% places them in the 0% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by ZHANG SPIERING, DONGXIU receive 5.00 office actions before reaching final disposition. This places the examiner in the 99% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ZHANG SPIERING, DONGXIU is 55 months. This places the examiner in the 2% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +0.0% benefit to allowance rate for applications examined by ZHANG SPIERING, DONGXIU. This interview benefit is in the 12% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 0.0% of applications are subsequently allowed. This success rate is in the 0% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 0% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.